VITROSCREEN ORA
DEAD

Serial Number

88892457

Owner

Vitroscreen S.r.l.

Attorney

Francesco Braga

Filing Date

Apr 29, 2020

Add to watchlist:

No watchlists yet
View on USPTO

VITROSCREEN ORA Trademark

Serial Number: 88892457

VITROSCREEN ORA is a trademark filed by Vitroscreen S.r.l. on April 29, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Vitroscreen S.r.l. (2 trademarks)

Milano 20149 , IT

Entity Type: 16

Trademark Details

Filing Date

April 29, 2020

Registration Date

Not Registered

Goods & Services

Stem cells not for implant in the human body; Bone void fillers consisting of biological materials; Bone void fillers comprised of living tissues, in the nature of miniaturized organs and tissue specific; 3D model mirroring phenotypic characteristic of the donor's cells and related metabolic pathways coltures in the nature of spheroids, primary cells, IPSC (Induced Pluripotent Stem Cell )derived cells cultivated as single type or in cocolture

Stem cell research, consisting in study of stem cells not for implant in human body; Scientific services relating to the isolation and cultivation of human tissues and cells, not for implant in human body; Biological research consisting of pre-clinical evaluations; Biological laboratory services consisting of pre-clinical evaluations; Biological research consultancy and analysis consisting of pre-clinical evaluations; Biology consultancy consisting of pre-clinical evaluations; Scientific research relating to biology; laboratory services, namely, Preparation of biological samples for research purposes consisting of pre-clinical evaluations in form, cosmetic, chemical and nutritional fields; laboratory services, namely, Preparation of biological samples for testing and analysis in research laboratories, namely, pre-clinical evaluations; Industrial and analysis research, namely, pre-clinic analysis of cosmetics and pharmaceutical and nutritional products", all the aforesaid services with the exclusion of conducting clinical trials, pharmaceutical drug development services and pharmaceutical and nutritional testing services

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 24, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 24, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 13, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 13, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 13, 2021 CNRT
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 17, 2021 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
May 17, 2021 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
May 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2021 CRFA
ASSIGNED TO LIE
May 10, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 27, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 28, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 23, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2020 NWOS
NEW APPLICATION ENTERED
May 2, 2020 NWAP